Mesa Laboratories, Inc. (MLAB)
127.40
+3.08
(+2.48%)
USD |
NASDAQ |
Aug 25, 16:00
127.40
0.00 (0.00%)
After-Hours: 18:19
Mesa Laboratories Price to Book Value : 3.777 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.686 |
| August 21, 2026 | 3.698 |
| August 20, 2026 | 3.532 |
| August 19, 2026 | 3.549 |
| August 18, 2026 | 3.200 |
| August 17, 2026 | 3.191 |
| August 14, 2026 | 3.144 |
| August 13, 2026 | 3.356 |
| August 12, 2026 | 3.344 |
| August 11, 2026 | 3.297 |
| August 10, 2026 | 3.012 |
| August 07, 2026 | 3.043 |
| August 06, 2026 | 2.994 |
| August 05, 2026 | 3.042 |
| August 04, 2026 | 2.998 |
| August 03, 2026 | 3.096 |
| July 31, 2026 | 2.988 |
| July 30, 2026 | 2.995 |
| July 29, 2026 | 2.954 |
| July 28, 2026 | 2.997 |
| July 27, 2026 | 2.898 |
| July 24, 2026 | 2.890 |
| July 23, 2026 | 2.993 |
| July 22, 2026 | 2.922 |
| July 21, 2026 | 2.891 |
| Date | Value |
|---|---|
| July 20, 2026 | 2.866 |
| July 17, 2026 | 2.903 |
| July 16, 2026 | 2.948 |
| July 15, 2026 | 2.807 |
| July 14, 2026 | 2.806 |
| July 13, 2026 | 2.815 |
| July 10, 2026 | 2.834 |
| July 09, 2026 | 2.828 |
| July 08, 2026 | 2.708 |
| July 07, 2026 | 2.851 |
| July 06, 2026 | 3.040 |
| July 02, 2026 | 3.129 |
| July 01, 2026 | 3.095 |
| June 30, 2026 | 2.951 |
| June 29, 2026 | 2.952 |
| June 26, 2026 | 3.038 |
| June 25, 2026 | 2.912 |
| June 24, 2026 | 2.802 |
| June 23, 2026 | 2.728 |
| June 22, 2026 | 2.766 |
| June 18, 2026 | 2.821 |
| June 17, 2026 | 2.817 |
| June 16, 2026 | 2.957 |
| June 15, 2026 | 3.088 |
| June 12, 2026 | 3.129 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agilent Technologies, Inc. | 6.133 |
| Bio-Rad Laboratories, Inc. | 1.454 |
| Bruker Corp. | 3.638 |
| Danaher Corp. | 2.887 |
| Harvard Bioscience, Inc. | 4.609 |
Price to Book Value Related Metrics
| PE Ratio | 150.73 |
| PS Ratio | 2.857 |
| Price to Free Cash Flow | 13.49 |
| Price | 127.40 |
| Earnings Yield | 0.66% |
| Market Cap | 712.90M |
| Operating PE Ratio | 31.74 |
| Normalized PE Ratio | 150.73 |